Champlain Investment Partners LLC purchased a new position in Phreesia, Inc. (NYSE:PHR – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,251,200 shares of the company’s stock, valued at approximately $29,941,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in PHR. International Assets Investment Management LLC raised its holdings in shares of Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after acquiring an additional 1,411 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in shares of Phreesia by 5,462.3% during the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after acquiring an additional 3,769 shares in the last quarter. Raymond James & Associates purchased a new stake in shares of Phreesia during the 4th quarter worth approximately $226,000. ProShare Advisors LLC raised its holdings in shares of Phreesia by 8.6% during the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock worth $228,000 after acquiring an additional 751 shares in the last quarter. Finally, Trust Point Inc. purchased a new stake in shares of Phreesia during the 4th quarter worth approximately $239,000. 92.10% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, CEO Chaim Indig sold 2,644 shares of the business’s stock in a transaction dated Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $62,768.56. Following the sale, the chief executive officer now owns 1,219,361 shares in the company, valued at $28,947,630.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Chaim Indig sold 2,644 shares of the business’s stock in a transaction dated Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $62,768.56. Following the sale, the chief executive officer now owns 1,219,361 shares in the company, valued at $28,947,630.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $25.00, for a total value of $175,000.00. Following the sale, the director now owns 30,653 shares in the company, valued at approximately $766,325. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,506 shares of company stock worth $375,299. 5.80% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Analysis on Phreesia
Phreesia Stock Up 1.7 %
Phreesia stock traded up $0.41 during trading hours on Tuesday, reaching $24.02. The stock had a trading volume of 302,374 shares, compared to its average volume of 492,821. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -10.88 and a beta of 0.93. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.76 and a quick ratio of 1.76. The business’s 50 day moving average price is $21.24 and its 200-day moving average price is $23.08. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $32.11.
Phreesia (NYSE:PHR – Get Free Report) last announced its earnings results on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.16. The business had revenue of $101.20 million during the quarter, compared to the consensus estimate of $100.94 million. Phreesia had a negative net margin of 31.87% and a negative return on equity of 46.89%. The firm’s revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the company posted ($0.70) earnings per share. Sell-side analysts anticipate that Phreesia, Inc. will post -1.16 EPS for the current year.
Phreesia Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Recommended Stories
- Five stocks we like better than Phreesia
- What is a Low P/E Ratio and What Does it Tell Investors?
- ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Leading Beverage Company’s Stock Bubbles Higher: Rally Ahead
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Can This Meme Stock Stage One Last Rally?
Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR – Free Report).
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.